Pharma Journalist - Page 52 of 946 -

Aurisco Passes FDA Inspection for Generic Oligonucleotide APIs

Alfasigma to Acquire Nordic Pharma in Global Expansion

Lilly Files Six Lawsuits Against Black-Market Retatrutide Sellers

FDA Approves First Gene Therapy for Broad SMA Patient Population

Vaximm Enters Talks for Global License of Oral Cancer Therapy

AstraZeneca to Invest $2 Billion in Major Maryland Expansion

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to $2.37 Billion

EU Grants Conditional Approval for Roche’s One-Minute Subcutaneous Lunsumio in Follicular Lymphoma

Novartis to Build Major U.S. Manufacturing Hub in North Carolina

FDA Approves Expanded Dosing Options for Regeneron’s EYLEA HD in Retinal Diseases

Moderna Expands U.S. Manufacturing with New Onshore Drug Product Facility

Merck’s Two-Drug HIV Regimen Meets Phase 3 Trial Goals

EC Approves First Simponi Biosimilar Gobivaz in Europe